1. Utility of glycated hemoglobin screening in patients undergoing elective coronary artery surgery:prospective, cohort study from the E-CABG registry
- Author
-
Nicolini, F. (Francesco), Santarpino, G. (Giuseppe), Gatti, G. (Giuseppe), Reichart, D. (Daniel), Onorati, F. (Francesco), Faggian, G. (Giuseppe), Dalén, M. (Magnus), Khodabandeh, S. (Sorosh), Fischlein, T. (Theodor), Maselli, D. (Daniele), Nardella, S. (Saverio), Rubino, A. S. (Antonino S.), De Feo, M. (Marisa), Salsano, A. (Antonio), Gherli, R. (Riccardo), Mariscalco, G. (Giovanni), Kinnunen, E.-M. (Eeva-Maija), Ruggieri, V. G. (Vito G.), Bounader, K. (Karl), Saccocci, M. (Matteo), Chocron, S. (Sidney), Airaksinen, J. (Juhani), Perrotti, A. (Andrea), and Biancari, F. (Fausto)
- Subjects
HbA1c ,diabetes ,CABG ,coronary artery bypass ,glycated hemoglobin - Abstract
Background: Patients with increased glycated hemoglobin (HbA1c) seem to be at increased risk of sternal wound infection (SWI) after coronary artery bypass grafting (CABG). However, it is unclear whether increased baseline HbA1c levels may affect other postoperative outcomes. Material and methods: Data on preoperative levels of HbA1c were collected from 2606 patients undergoing elective isolated CABG from 2015 to 2016 and included in the prospective, multicenter E-CABG registry. Results: The prevalence of HbA1c ≥ 53 mmol/mol (7.0%) among non-diabetics was 5.3%, among non-insulin dependent diabetics was 53.5% and among insulin dependent diabetics was 67.1% (p 75 mmol/mol (9.0%) among non-diabetics was 0.5%, among non-insulin dependent diabetics was 5.8% and among insulin dependent diabetics was 10.6% (p
- Published
- 2018